Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.5K Sell
1,940
-165
-8% -$5.87K 0.01% 363
2026
Q1
$63.2K Buy
2,105
+1,361
+183% +$43.2K 0.01% 392
2025
Q4
$22.2K Buy
744
+271
+57% +$7.17K ﹤0.01% 820
2025
Q3
$12.2K Buy
473
+460
+3,538% +$11.4K ﹤0.01% 1159
2025
Q2
$297 Buy
+13
New +$267 ﹤0.01% 930

Other funds holding IX

Salomon & Ludwin's IX Position: Q2 2026 in Review

Salomon & Ludwin reduced its ORIX (IX) stake by 7.8% in Q2 2026, selling an estimated $5.87K and leaving 1,940 shares worth $74.5K. The position accounts for 0.01% of the portfolio, ranked #363.

Salomon & Ludwin first reported a position in IX in Q2 2025 and has held it in 5 quarters since. 320 funds tracked by Wall St. Rank hold IX as of Q2 2026.

  • Salomon & Ludwin held 1,940 shares of ORIX worth $74.5K as of Q2 2026.
  • Salomon & Ludwin sold 165 ORIX shares in Q2 2026, an estimated $5.87K.
  • ORIX made up 0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #363 holding.
  • Salomon & Ludwin first reported a position in ORIX in Q2 2025 and has held it in 5 quarters since.
  • 320 funds tracked by Wall St. Rank held ORIX as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.